A multi-cancer blood test, in plain English
A multi-cancer blood test looks for traces that tumours can release into the blood, such as fragments of DNA, and checks for a signal from many cancer types at once. Where it finds one, it may suggest where in the body the signal comes from.
It is an emerging test, and none has been authorized by the FDA. A positive result needs imaging and other tests to confirm it, a negative result does not mean no cancer is present, and it is offered in addition to guideline cancer screening rather than instead of it. Multi-cancer early detection blood testing is offered under brands like Galleri.
Cancer in San Francisco, by the numbers
The rate of past cancer diagnoses in San Francisco is lower than the national rate. About 1 in 15 adults in San Francisco have ever been diagnosed with cancer, other than common skin cancers, compared with about 1 in 13 nationally. That adds up to roughly 240,000 adults across five counties.
By county
| County | Cancer (other than skin cancer) | Colorectal screening up to date (ages 45 to 75) | Mammogram in the past 2 years (women 50 to 74) |
|---|---|---|---|
| Alameda | 5.9% | 59.5% | 74.5% |
| Contra Costa | 7.0% | 64.0% | 75.9% |
| San Francisco | 6.0% | 61.9% | 78.6% |
| San Mateo | 6.8% | 63.9% | 79.3% |
| Marin | 10.5% | 65.4% | 78.3% |
| San Francisco | 6.6% | 62.1% | 76.6% |
| United States | 7.8% | 63.8% | 76.1% |
Source: CDC PLACES, 2022 and 2023 county estimates. San Francisco = San Francisco, Alameda, Contra Costa, San Mateo and Marin counties, weighted by adult population.
longevityclinicshub.comYour regular doctor can tell you which standard screenings are due for your age. Those come first, and the newer tests above are extras, not replacements.
